Axon Shares Drop 1.03% as Trading Volume Plummets 39% to $280M Ranking 410th in Market Activity Amid Institutional Buys and Analyst Upgrades

On July 29, 2025, Axon (AXON) traded with a 1.03% decline, closing at $736.29. Daily trading volume fell to $280 million, a 39.25% drop from the previous day, ranking the stock 410th in market activity. Institutional investor activity highlighted shifting positions, with Assetmark Inc. increasing its stake by 5.9% in Q1 and Bartlett & CO. Wealth Management LLC boosting holdings by 132% to $31,000. Meanwhile, Catalyst Capital Advisors and Alpine Bank Wealth Management each initiated new positions valued at $32,000 and $40,000, respectively.

Analyst activity remained robust, with Goldman Sachs upgrading its price target to $830 and Morgan Stanley assigning an "overweight" rating. However, insider transactions revealed caution, as Director Michael Garnreiter reduced holdings by 25% through a $4.5 million share sale, and CRO Cameron Brooks sold 3,000 shares for $2.22 million. Institutional ownership now accounts for 79.08% of the company’s stock, reflecting continued institutional confidence despite recent insider divestments.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day resulted in a 166.71% return from 2022 to the present, significantly outperforming the benchmark return of 29.18%. The strategy's excess return was 137.53%, and it achieved a CAGR of 31.89%. With a maximum drawdown of 0.00% and a Sharpe ratio of 1.14, the strategy demonstrated strong risk-adjusted performance and capital preservation.